AstraZeneca doubles down on digital health in its latest collaboration

AstraZeneca is going down the digital health route in its newest deal, focusing on decentralized clinical trials and virtual healthcare.

The UK pharma has teamed up again with digital health firm Huma Therapeutics in a bid to “scale innovation for digital health,” Huma said in a statement early Wednesday.